Key Insights From The Cancer Medicines Forum Workshop – EORTC
EORTC – European Organisation for Research and Treatment of Cancer made the following post on LinkedIn:
“Who not to treat? When and how long to treat? How can toxicity be reduced and effectiveness maintained or even improved? These are some of the questions that treatment optimisation research aims to answer.
Last month we gathered in Amsterdam for the Cancer Medicines Forum workshop, organised in collaboration with the European Medicines Agency and under the auspices of the Belgian Presidency of the Council of the European Union 2024.
The workshop provided an opportunity to discuss the current status and next steps of treatment optimisation research, emphasising the importance of independent clinical research organisations such as EORTC in determining the optimal use of anticancer medicines.
Read the article to delve into the key insights from the workshop.”
Source: EORTC/LinkedIn
OncoDaily